BioSpace News Archive

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the 40th Annual J.P. Morgan Virtual Healthcare Conference on Monday, Jan. 10, at 7:30 a.m. EST.

Amyris, Inc. (Nasdaq: AMRS), and ImmunityBio (Nasdaq: IBRX), today announced the completion of a previously announced joint venture agreement to accelerate the commercialization of a leading next-generation COVID-19 vaccine.

Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, today announced the launch of its initial public offering of 8,750,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (“SEC”).

According to Emergen Research, the global patient registry software market size was USD 1.10 Billion in 2019 and is expected to reach USD 2.96 Billion in 2027 and register a revenue CAGR of 13.9% during the forecast period, 2020-2027.

The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and ML to enhance efficiency of medical products.

The industry analysis report is considered a valuable source of information about the global Bovine Vaccines industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and ML to enhance efficiency of medical products.

Therapeutic Solutions International (TSOI) announced today positive results of a pilot clinical trial in 20 subjects.

MaaT Pharma announced that its CEO and co-founder, Hervé Affagard will present the company at the upcoming H.C. Wainwright Bioconnect Virtual Conference held January 10-13, 2022.

iTeos Therapeutics, Inc. announced that Michel Detheux, Ph.D., President and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Conference being held virtually on Tuesday, January 11, 2022 at 11:15 a.m. ET.